EMMA's free cash flow for Q2 2023 was $-1.32M. For the 2023 fiscal year, EMMA's free cash flow was decreased by $-3.77M and operating cash flow was $-1.32M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Sep 18
Operating Cash Flow	$ -1.87M	$ -5.07M	$ -1.25M	$ -2.45M	$ -4.52M	$ -9.04M
Investing Cash Flow	$ -1.99M	$ -2.39M	$ -6.38M	$ 5.47M	$ -1.48M	$ -361.80K
Financing Cash Flow	$ 4.27M	$ 7.23M	$ 7.41M	$ -2.31M	$ 3.88M	$ 7.21M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 6.32M	$ 2.02M	$ 2.28M	$ 2.49M	$ 1.77M	$ 3.25M
Income Tax Paid Supplemental Data	$ -80.00K	$ 4.00K	$ 21.00K	$ 144.00K	$ 227.00K	$ 1.90K
Interest Paid Supplemental Data	$ 2.07M	$ 1.33M	$ 945.00K	$ 1.48M	$ 1.54M	$ 8.20K
Issuance Of Capital Stock	-	-	-	$ 142.00K	$ 8.59M	$ 2.97M
Issuance Of Debt	$ 5.87M	$ 7.23M	$ 7.41M	$ 2.77M	$ 600.00K	-
Repayment Of Debt	$ -4.74M	$ -3.13M	$ -8.78M	$ -5.22M	$ -5.49M	$ -75.80K
Free Cash Flow	$ -1.89M	$ -5.10M	$ -1.33M	$ -2.47M	$ -4.58M	$ -9.09M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Emmaus Life Sciences Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing